Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles

By Matsumura Yasuhiro  

Journal of Drug Targeting, Vol. 15, Iss. 7-8, 2007-08 ,pp. : 507-517

Informa Healthcare

Access to resources Recommend Favorite

Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas

By Maruo Takeshi   Ohara Noriyuki   Yoshida Shigeki   Nakabayashi Koji   Sasaki Hiroko   Xu Qin   Matsuo Hiroya   Sitruk-Ware Regine   Yamada Hideto  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 9, 2011-09 ,pp. : 897-911

Informa Healthcare

Access to resources Recommend Favorite

Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?

By  

Current Medicinal Chemistry, Vol. 25, Iss. 31, 2018-09 ,pp. : 3682-3702

Bentham Science Publishers

Access to resources Recommend Favorite

Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies

By  

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 338-346

Bentham Science Publishers

Access to resources Recommend Favorite